Study confirmed effective, less toxic alternative to standard treatment for adults with Burkitt lymphoma
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
On Dec. 2, 1985, the first clinical tests were held at the University of Washington of erythropoietin (EPO),…
On Jun. 17, 1983, Applied Molecular Genetics (AMGen), led by CFO Gordon Binder issued its Initial Public Offering…
In 1983, Amgen scientists isolated the gene that creates EPO and filed a patent. Pioneering studies on erythropoietin…
In 1977, Eugene Goldwasser published Purification of Human Erythropoietin (EPO) in the Journal of Biological Chemistry. Goldwasser spent…